Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.3 USD | -2.03% | -2.45% | -17.91% |
05-13 | Mizuho Adjusts Price Target on Insmed to $36 From $35, Keeps Buy Rating | MT |
05-10 | Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.91% | 3.84B | |
+4.46% | 111B | |
+11.40% | 105B | |
-12.32% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.99% | 16.96B | |
+2.74% | 13.7B | |
+36.92% | 12.45B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated, Q1 2023 Earnings Call, May 04, 2023